Emerald Mutual Fund Advisers Trust Deciphera Pharmaceuticals, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

$1.77 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$13.58 - $17.36 $4.05 Million - $5.18 Million	298,131 Added 56.65%	824,402 $13 Million
Q4 2023 Feb 05, 2024	BUY	$10.11 - $16.54 $5.32 Million - $8.7 Million	526,271 New	526,271 $8.49 Million
Q2 2021 Jul 29, 2021	SELL	$32.73 - $47.95 $10.4 Million - $15.3 Million	-319,202 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$51.77 - $66.18 $3.7 Million - $4.73 Million	71,454 Added 28.84%	319,202 $18.2 Million
Q3 2020 Oct 28, 2020	BUY	$43.8 - $58.16 $2.51 Million - $3.33 Million	57,266 Added 30.06%	247,748 $12.7 Million
Q2 2020 Jul 28, 2020	BUY	$37.05 - $65.03 $3.45 Million - $6.05 Million	93,050 Added 95.5%	190,482 $11.4 Million
Q1 2020 Apr 30, 2020	BUY	$33.63 - $69.4 $3.28 Million - $6.76 Million	97,432 New	97,432 $4.01 Million
Q3 2019 Oct 31, 2019	SELL	$19.95 - $38.85 $7.26 Million - $14.1 Million	-364,105 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$20.65 - $29.55 $5.15 Million - $7.36 Million	-249,176 Reduced 40.63%	364,105 $8.45 Million
Q4 2018 Jan 31, 2019	SELL	$19.08 - $36.14 $1.03 Million - $1.95 Million	-53,981 Reduced 8.09%	613,281 $12.9 Million
Q3 2018 Oct 31, 2018	BUY	$33.57 - $42.1 $5.21 Million - $6.53 Million	155,082 Added 30.28%	667,262 $25.8 Million
Q2 2018 Jul 31, 2018	BUY	$20.06 - $44.95 $1.59 Million - $3.56 Million	79,120 Added 18.27%	512,180 $20.2 Million
Q1 2018 Apr 26, 2018	BUY	$20.04 - $29.71 $335,028 - $496,691	16,718 Added 4.02%	433,060 $8.68 Million
Q4 2017 Feb 06, 2018	BUY	$16.54 - $24.2 $2.05 Million - $3.01 Million	124,195 Added 42.51%	416,342 $9.44 Million
Q3 2017 Oct 30, 2017	BUY	$17.65 - $18.99 $5.16 Million - $5.55 Million	292,147	292,147 $5.55 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account